Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Rangering i aksjer #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Aksjekurs
$2.37
Sist synkronisert: 2025-12-15
Markedsverdi
$3.99M
Endring (1 dag)
-5.58%
Endring (1 år)
24.74%
Land
US
Handel Qualigen Therapeutics, Inc. (QLGN)

Kategori

Aksjeprishistorikk for Qualigen Therapeutics, Inc. (QLGN)
Høyeste sluttskurs: $2.47 den 2025-12-01

Laveste sluttskurs: $589.38K den 2015-06-01
Aksjeprishistorikk for Qualigen Therapeutics, Inc. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 21.69%
2025 -41.50%
2024 -86.58%
2023 -55.56%
2022 -87.61%
2021 -67.06%
2020 -20.04%
2019 -75.35%
2018 -77.36%
2017 -88.49%
2016 37.25%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE